Zhaoke Ophthalmology Limited has dispatched a circular convening its 2026 Annual General Meeting (AGM) for 15 May 2026, 3:00 p.m., at Unit 716, 7/F, Building 12W, Phase 3, Hong Kong Science Park, Shatin.

Key resolutions to be tabled:

1. Capital management authorities • Share Repurchase Mandate: Directors seek authority to buy back up to 10% of the issued share capital (excluding treasury shares) in the period to the next AGM. • Issue Mandate: Board requests approval to allot and issue (or transfer treasury shares) up to 20% of the issued share capital, with an additional top-up equal to shares repurchased under the above mandate.

2. Board composition • Re-election of three retiring directors: – Dr Li Xiaoyi (Executive Director, Chairman & CEO) – Ms Tiantian Zhang (Non-executive Director) – Mr Liew Fui Kiang (Independent Non-executive Director) All have offered themselves for re-election following Nomination Committee endorsement.

3. Auditor re-appointment • Renewal of KPMG’s mandate as external auditor until the next AGM, with the Board authorised to fix remuneration.

4. Amendments to Articles of Association • Proposed changes cover provisions for hybrid/electronic meetings, electronic voting, treatment of treasury shares and alignment with updated Hong Kong Listing Rules and Cayman Islands requirements.

Logistics and timetable:

• Register of members closes 12 – 15 May 2026 (both days inclusive); share transfers for voting eligibility must be lodged by 4:30 p.m. on 11 May 2026. • Proxy forms must reach Computershare Hong Kong Investor Services by 3:00 p.m. on 13 May 2026. • All AGM resolutions will be decided by poll, with results released through the Stock Exchange.

The Board recommends shareholders vote in favour of all proposals, noting no immediate plan to utilise the requested share repurchase or issuance mandates.